Prescribing Opioid Analgesics: General Precautions

Prescribing opioids are not without risks. However, opioids continue to be prescribed for acute and chronic pain given that they have been shown to be an effective treatment for certain individuals. Consistent with all prescribed medications, it is important for the prescriber to be aware of common side effects and their management, as well as potential serious side effects and their management. These recommendations are designed to minimize harm to the patient, their loved ones/caregivers, as well as to inform the prescriber about best practices. This session will provide clinicians with an overview of general precautions necessary when prescribing opioids.

Learning Objectives

  • Summarize counseling strategies for patients on opioid therapy.
  • Recognize signs of an opioid overdose.

Additional Information

Partner: 
Pri-Med Institute
Course summary
Available credit: 
  • 0.50 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
02/23/2022
Course expires: 
02/23/2023
Rating: 
0

Charles E. Argoff, MD, FABPM

Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Albany, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair
Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Philadelphia, PA

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Charles E. Argoff, MD: Advisor for BioDelivery Sciences International, Inc.; Clexio Bioscience; Neumentum; Nevro; Regeneron Pharmaceuticals; SK Life Sciences; Tremeau Pharmaceuticals Inc.; Teva Pharmaceuticals; and Vertex. Consulting for EnZen; Opioid PMR Consortium; and Xgene. Services Provided for Collegium.

Katherine E. Galluzzi, DO, CMD, FACOFP: No relevant financial relationships disclosed.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

AMA PRA Category 1 Credits™

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 0.50 contact hour of continuing education, which includes 0.00 hours of pharmacology.

Available Credit

  • 0.50 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through Pri-Med. 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch

Topics